Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia

F. Caligaris-Cappio, G. Pizzolo, M. Chilosi, L. Bergui, G. Semenzato, L. Tesio, L. Morittu, F. Malavasi, M. Gobbi, R. Schwarting

Research output: Contribution to journalArticle

Abstract

We have investigated the relationship between chronic lymphocytic leukemia (CLL), hair cell leukemia (HCL), and different normal B cell subsets: Mrbc+, T1+ and slgM+ tonsil cells; germinal center; mantle zone; and peripheral blood B lymphocytes. Both malignant and normal cells were incubated in vitro with the phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate (TPA) for 72 hours and the morphology, cytochemical profile, and surface markers were evaluated. The results show that CLL cells TPA-induced become indistinguishable from HCL by four independent criteria: the morphology; the cytoplasmic tartrate-resistant acid phosphatase (TRAP) enzyme activity; the membrane positivity with anti-Leu M5 (SHCL3); and anti-Tac monoclonal antibodies which, in the uninduced state, react only with HCL. The features of TRAP and Tac positivity are also expressed (though in variable degree) by different normal B cell populations activated with TPA or pokeweed mitogen (PWM). It is concluded that HCL might represent an aberrantly activated variant of CLL (or of a CLL-related disorder).

Original languageEnglish
Pages (from-to)1035-1042
Number of pages8
JournalBlood
Volume66
Issue number5
Publication statusPublished - 1985

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia'. Together they form a unique fingerprint.

  • Cite this

    Caligaris-Cappio, F., Pizzolo, G., Chilosi, M., Bergui, L., Semenzato, G., Tesio, L., Morittu, L., Malavasi, F., Gobbi, M., & Schwarting, R. (1985). Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia. Blood, 66(5), 1035-1042.